𝔖 Bobbio Scriptorium
✦   LIBER   ✦

First-line treatment of Hodgkin’s lymphoma

✍ Scribed by Beate Klimm; Andreas Engert; Volker Diehl

Book ID
107540144
Publisher
Current Science Inc.
Year
2006
Tongue
English
Weight
337 KB
Volume
1
Category
Article
ISSN
1558-8211

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A pilot study on the use of the proMACE-
A pilot study on the use of the proMACE-cytaBOM regimen as a first-line treatment of advanced follicular non-Hodgkin's lymphoma
✍ Luca Baldini; Andrea Guffanti; Paolo Gobbi; Mariangela Colombi; Massimo Federico 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views

## Background: The role of intensive conventional dose chemotherapy in advanced low grade non-hodgkin's lymphomas is a matter of debate. the gruppo italiano per lo studio dei linfomi conducted a study to evaluate the efficacy and toxicity of a third-generation polychemotherapeutic regimen, promace-

The treatment of non-Hodgkin's lymphoma
The treatment of non-Hodgkin's lymphoma
✍ Samuel Hellman; David S. Rosenthal; William C. Moloney; John T. Chaffey 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 432 KB 👁 2 views

Much of the approach to evaluation and management of the non-Hodgkin's lymphomas has been modeled after Hodgkin's disease. However, as the name implies, they are quite different. The non-Hodgkin's lymphomas are a group of diseases and syndromes. These many different presentations, syndromes, and pos

Treatment of hodgkin's disease and other
Treatment of hodgkin's disease and other malignant lymphomas
✍ C. W. Aungst 📂 Article 📅 1973 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB

## Abstract Considerable progress has been made in the treatment of Hodgkin's disease and the other lymphomas during the past 15 years. The present paper summarizes, in part, studies which our department has conducted or in which we have participated during this period. Studies of chlorambucil, pre